Efficacy and Safety of a Protocol Using C-reactive Protein to Guide Antibiotic Therapy

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions
Systemic Infection
Interventions
OTHER

C reactive protein algorithm

"Antibiotic therapy discontinuation will be encouraged under the following conditions:~If the peak CRP is below 100 mg/L: Consider stopping antibiotics when CRP falls below 35 mg/L, with a minimum treatment duration of 3 days.~If the peak CRP is above 100 mg/L or the patient meets criteria for sepsis or septic shock: Consider stopping antibiotics when CRP has decreased by 50%, after a minimum of 5 days.~If the patient does not meet the CRP criteria: Antibiotic discontinuation will be recommended after 5-7 days, provided there is clinical improvement.~Before discontinuing antibiotic therapy, physicians should confirm that the patient is clinically improving, with no signs of a persistent infectious focus. Additionally, they will be encouraged to verify that the Sequential Organ Failure Assessment (SOFA) score is stable or decreasing. These factors will assist in determining the appropriateness of stopping antibiotics."

Trial Locations (1)

30130100

Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte

All Listed Sponsors
collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

collaborator

FAPEMIG - Fundação de Amparo a Pesquisa do Estado de Minas Gerais

UNKNOWN

lead

Federal University of Minas Gerais

OTHER